Growth factors mediated cell signalling in prostate cancer progression: Implications in discovery of anti-prostate cancer agents
- 1 October 2015
- journal article
- review article
- Published by Elsevier in Chemico-Biological Interactions
- Vol. 240, 120-133
Abstract
No abstract availableKeywords
Funding Information
- DST (SR/FT/CS-71/2011)
- UGC-Major (42–676/2013)
This publication has 114 references indexed in Scilit:
- Genetics and genomics of prostate cancerAsian Journal of Andrology, 2013
- Activation of NF-kappa B Signaling Promotes Growth of Prostate Cancer Cells in BonePLOS ONE, 2013
- New Therapeutics to Treat Castrate‐Resistant Prostate CancerThe Scientific World Journal, 2013
- Interleukin-6: A multifunctional targetable cytokine in human prostate cancerMolecular and Cellular Endocrinology, 2012
- GPRC6A regulates prostate cancer progressionThe Prostate, 2011
- Differential roles of ERK and Akt pathways in regulation of EGFR-mediated signaling and motility in prostate cancer cellsOncogene, 2010
- Inhibiting TNF-mediated signaling: a novel therapeutic paradigm for androgen independent prostate cancerApoptosis, 2009
- Suppression of Wnt/β-catenin signaling inhibits prostate cancer cell proliferationEuropean Journal of Pharmacology, 2009
- Apigenin suppresses insulin‐like growth factor I receptor signaling in human prostate cancer: An in vitro and in vivo studyMolecular Carcinogenesis, 2008
- Oncomirs — microRNAs with a role in cancerNature Reviews Cancer, 2006